Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Forecast Analysis Through 2030 With Insights On Industry Expansion
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2026 And How Much Will It Reach By 2030?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market has experienced significant expansion in its size during recent years. This market is anticipated to expand from $1.69 billion in 2025 to $2.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.6%. Historically, this growth can be attributed to factors such as the increasing utilization of intravenous therapies in clinical care, a rise in the incidence of infusion-related complications, the broadening of hospital patient monitoring systems, the growing embrace of smart infusion devices, and an intensified focus on medication safety protocols.
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market is expected to experience substantial growth in the upcoming years. It is projected to reach $4.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 21.3%. The expansion during this forecast period can be attributed to the increasing adoption of AI-enabled infusion monitoring, a rising demand for home-based iv therapy solutions, the broadening of predictive patient safety analytics, the growing integration of connected infusion systems, and an increasing focus on remote clinical monitoring. Prominent trends anticipated in the forecast period include the wider adoption of real-time iv flow analytics, the rising use of AI-based infusion error detection, the growing integration of smart infusion sensors, the expansion of remote iv therapy management, and an enhanced emphasis on patient safety and compliance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28921&type=smp
Which Growth Factors Are Strengthening The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Landscape?
The increasing adoption of telehealth services is anticipated to fuel the expansion of the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market moving forward. Telehealth involves delivering healthcare through digital communication technologies for remote medical consultations, monitoring, and treatment. Its growth stems from regulatory adjustments and reimbursement structures put in place during the COVID-19 pandemic, which made virtual healthcare more accessible and financially viable for both healthcare providers and patients. AI-enhanced remote patient intravenous (IV) monitoring supports telehealth by allowing real-time, distant tracking of patients’ IV therapy, automatically identifying complications, offering actionable insights to healthcare professionals, and integrating smoothly with virtual care platforms. This ensures prompt interventions, enhanced patient safety, and more efficient management of treatments at home and in outpatient settings. For instance, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that in 2023, national telehealth utilization grew by 7.3%, increasing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the proliferation of telehealth services is accelerating the development of the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market.
What Are The Core Segment Classifications In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications
4) By End-User: Healthcare Providers, Patients
Subsegments:
1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems
2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software
3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services
Who Are The Businesses Driving Activity In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
Major companies operating in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.
Access The Complete Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Report:
Which Region Commands The Largest Share Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28921&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market 2026, By The Business Research Company
Ai In Medical Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Artificial Intelligence Or Machine Learning Ai Or Ml Medical Device Global Market Report 2026
Artificial Intelligence In Healthcare Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
